March 11, 2020 / 10:21 AM / in 25 days

BRIEF-Xeris Pharmaceuticals Reports Q4 Loss Per Share Of $1.23

March 11 (Reuters) - Xeris Pharmaceuticals Inc:

* XERIS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND HIGHLIGHTS PIPELINE PROGRESS

* Q4 LOSS PER SHARE $1.23

* Q4 EARNINGS PER SHARE ESTIMATE $-1.13 — REFINITIV IBES DATA

* XERIS PHARMACEUTICALS - CO IS ON TRACK FOR ITS PLANNED LAUNCH OF GVOKE HYPOPEN, ITS LIQUID STABLE GLUCAGON IN AN AUTO-INJECTOR, IN JULY 2020

* XERIS PHARMACEUTICALS -AS OF DEC 31, 2019, XERIS REPORTED TOTAL CASH, CASH EQUIVALENTS, AND INVESTMENTS OF $88.8 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below